Aurinia Pharmaceuticals Inc. (AUPH)

Aurinia Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-22.55	-78.02	-108.18	-180.97	-102.68	-88.39
Depreciation & Amortization	19.53	11.65	2.71	2.76	1.37	1.17
Loss (Gain) From Sale of Investments	-13.06	-12.14	-1.57	0.66	-	-
Stock-Based Compensation	34.42	45.31	32.3	31.24	17.45	7.41
Other Operating Activities	7.85	5.35	2.03	10.24	9.48	14.19
Change in Accounts Receivable	1.46	-10.61	1.93	-15.42	-0.65	-0.15
Change in Inventory	-5.89	-15.87	-9.07	-5.64	-13.93	-
Change in Accounts Payable	2.52	13.39	0.7	4.08	13.62	4.01
Change in Unearned Revenue	3.76	3.76	3.05	-	-	-
Change in Other Net Operating Assets	0.55	3.71	-3.42	-4.65	5.48	-1.83
Operating Cash Flow	28.59	-33.46	-79.53	-157.69	-69.86	-63.59
Capital Expenditures	-0.3	-0.72	-0.29	-0.3	-5.67	-0.09
Sale (Purchase) of Intangibles	0.02	-	-	-1.2	-1.68	-0.02
Investment in Securities	-5.89	5.88	-59.68	-84.53	-150.84	7.88
Other Investing Activities	-0.04	-11.86	-0.66	-17.84	-	-
Investing Cash Flow	-6.22	-6.71	-60.63	-103.87	-158.19	7.78
Long-Term Debt Repaid	-	-10.03	-	-	-	-
Net Debt Issued (Repaid)	-15.5	-10.03	-	-	-	-
Issuance of Common Stock	2.31	4.9	2.43	221.11	194.38	257.48
Other Financing Activities	-	-	-	-	-	-13.63
Financing Cash Flow	-31.62	-5.13	2.43	221.11	194.38	243.85
Net Cash Flow	-9.26	-45.3	-137.73	-40.45	-33.67	188.05
Free Cash Flow	28.29	-34.18	-79.82	-158	-75.53	-63.67
Free Cash Flow Margin	12.84%	-19.47%	-59.55%	-346.44%	-150.70%	-20022.01%
Free Cash Flow Per Share	0.20	-0.24	-0.56	-1.22	-0.64	-0.68
Cash Income Tax Paid	1.62	0.5	1.98	0.26	0.26	0.06
Levered Free Cash Flow	38.91	-3.89	-35.1	-98.48	-45.77	-46.45
Unlevered Free Cash Flow	42.03	-2.16	-35.1	-98.48	-45.77	-46.45
Change in Net Working Capital	-0.27	4.78	0.15	18.03	-7.93	-1.91

Source: S&P Capital IQ. Standard template. Financial Sources.